These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes. Potsis TZ; Katsouras C; Goudevenos JA Angiology; 2009; 60(2):148-58. PubMed ID: 18508853 [TBL] [Abstract][Full Text] [Related]
3. The medical management of acute coronary syndromes and potential roles for new antithrombotic agents. Pollack CV; Goldberg AD J Emerg Med; 2008 May; 34(4):417-28. PubMed ID: 18226874 [TBL] [Abstract][Full Text] [Related]
4. Impact of home warfarin use on treatment patterns and bleeding complications for patients with non-ST-segment elevation acute coronary syndromes: observations from the CRUSADE quality improvement initiative. Wang TY; Chen AY; Peterson ED; Becker RC; Gibler WB; Ohman EM; Roe MT Eur Heart J; 2008 May; 29(9):1103-9. PubMed ID: 18353757 [TBL] [Abstract][Full Text] [Related]
5. Association between bleeding, blood transfusion, and costs among patients with non-ST-segment elevation acute coronary syndromes. Rao SV; Kaul PR; Liao L; Armstrong PW; Ohman EM; Granger CB; Califf RM; Harrington RA; Eisenstein EL; Mark DB Am Heart J; 2008 Feb; 155(2):369-74. PubMed ID: 18215610 [TBL] [Abstract][Full Text] [Related]
6. Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial. Tricoci P; Lokhnygina Y; Berdan LG; Steinhubl SR; Gulba DC; White HD; Kleiman NS; Aylward PE; Langer A; Califf RM; Ferguson JJ; Antman EM; Newby LK; Harrington RA; Goodman SG; Mahaffey KW Circulation; 2007 Dec; 116(23):2669-77. PubMed ID: 18025532 [TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S; Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665 [TBL] [Abstract][Full Text] [Related]
8. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ; Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590 [TBL] [Abstract][Full Text] [Related]
9. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial. Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426 [TBL] [Abstract][Full Text] [Related]
10. Acute Coronary Syndromes and Percutaneous Coronary Interventions: impact of bleeding and blood transfusion. Bassand JP Hamostaseologie; 2009 Nov; 29(4):381-7. PubMed ID: 19882079 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of anticoagulation strategies in non-ST-elevation acute coronary syndromes. Maxwell CB; Holdford DA; Crouch MA; Patel DA Ann Pharmacother; 2009 Apr; 43(4):586-95. PubMed ID: 19336655 [TBL] [Abstract][Full Text] [Related]
16. The risk of iatrogenic bleeding in acute coronary syndromes and long-term mortality. Sobieraj-Teague M; Gallus AS; Eikelboom JW Curr Opin Cardiol; 2008 Jul; 23(4):327-34. PubMed ID: 18520716 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications and management of bleeding events in patients with acute coronary syndromes. De Luca L; Casella G; Lettino M; Fradella G; Toschi V; Conte MR; Ottani F; Geraci G; Visconti LO; Tubaro M; Maggioni AP J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):677-86. PubMed ID: 19531962 [TBL] [Abstract][Full Text] [Related]
18. Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. Joyner CD; Peters RJ; Afzal R; Chrolavicius S; Mehta SR; Fox KA; Granger CB; Franzosi MG; Flather M; Budaj A; Bassand JP; Yusuf S Am Heart J; 2009 Mar; 157(3):502-8. PubMed ID: 19249421 [TBL] [Abstract][Full Text] [Related]
19. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction. Manoukian SV Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355 [TBL] [Abstract][Full Text] [Related]
20. Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6. Karthikeyan G; Mehta SR; Eikelboom JW Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):241-9. PubMed ID: 19296760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]